Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025
Lifecore Biomedical (NASDAQ: LFCR), a contract development and manufacturing organization (CDMO), has scheduled its third quarter fiscal 2025 financial results announcement for Thursday, April 3, 2025, after market close.
The company's senior management team will host a webcast at 4:30 p.m. Eastern Time to discuss the quarterly results and recent corporate developments. The webcast will be accessible through Lifecore's Investor Events & Presentations webpage, with an archived version available for 30 days following the live presentation.
Lifecore Biomedical (NASDAQ: LFCR), un'organizzazione di sviluppo e produzione su contratto (CDMO), ha programmato l'annuncio dei suoi risultati finanziari per il terzo trimestre dell'anno fiscale 2025 per giovedì 3 aprile 2025, dopo la chiusura del mercato.
Il team di alta direzione dell'azienda ospiterà un webcast alle 16:30 ora orientale per discutere i risultati trimestrali e i recenti sviluppi aziendali. Il webcast sarà accessibile attraverso la pagina web degli Eventi e Presentazioni per Investitori di Lifecore, con una versione archiviata disponibile per 30 giorni dopo la presentazione dal vivo.
Lifecore Biomedical (NASDAQ: LFCR), una organización de desarrollo y fabricación por contrato (CDMO), ha programado el anuncio de sus resultados financieros del tercer trimestre del ejercicio 2025 para jueves 3 de abril de 2025, después del cierre del mercado.
El equipo de alta dirección de la empresa llevará a cabo un webcast a las 4:30 p.m. hora del Este para discutir los resultados trimestrales y los recientes desarrollos corporativos. El webcast será accesible a través de la página de Eventos y Presentaciones para Inversores de Lifecore, con una versión archivada disponible durante 30 días después de la presentación en vivo.
Lifecore Biomedical (NASDAQ: LFCR), 계약 개발 및 제조 조직(CDMO)은 2025 회계연도 3분기 재무 결과 발표를 2025년 4월 3일 목요일, 시장 마감 후로 예정했습니다.
회사의 고위 경영진 팀은 동부 표준시 오후 4시 30분에 분기 결과 및 최근 기업 발전에 대해 논의하기 위해 웹캐스트를 개최합니다. 웹캐스트는 Lifecore의 투자자 이벤트 및 프레젠테이션 웹페이지를 통해 접근할 수 있으며, 라이브 프레젠테이션 후 30일 동안 아카이브 버전이 제공됩니다.
Lifecore Biomedical (NASDAQ: LFCR), une organisation de développement et de fabrication sous contrat (CDMO), a prévu l'annonce de ses résultats financiers du troisième trimestre de l'exercice 2025 pour jeudi 3 avril 2025, après la fermeture du marché.
L'équipe de direction de l'entreprise animera un webcast à 16h30, heure de l'Est, pour discuter des résultats trimestriels et des récents développements de l'entreprise. Le webcast sera accessible via la page Web des Événements et Présentations pour Investisseurs de Lifecore, avec une version archivée disponible pendant 30 jours après la présentation en direct.
Lifecore Biomedical (NASDAQ: LFCR), eine Vertragsentwicklungs- und -produktionsorganisation (CDMO), hat die Bekanntgabe ihrer Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2025 für Donnerstag, den 3. April 2025, nach Börsenschluss angesetzt.
Das Senior Management-Team des Unternehmens wird um 16:30 Uhr Eastern Time ein Webcast veranstalten, um die Quartalsergebnisse und aktuelle Unternehmensentwicklungen zu besprechen. Der Webcast wird über die Investorenevents- und Präsentationsseite von Lifecore zugänglich sein, mit einer archivierten Version, die 30 Tage nach der Live-Präsentation verfügbar ist.
- None.
- None.
Webcast Scheduled for Thursday, April 3 at 4:30 p.m. Eastern
CHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss financial results for the quarter and review recent corporate developments.
To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore’s website at: https://ir.lifecore.com/events-presentations. Following the live webcast, an archived version of the webcast will be available on the company’s website for 30 days.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
Lifecore Biomedical, Inc. Contact Information: Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) 415-675-7402 tbrons@vidasp.com Ryan D. Lake (CFO) Lifecore Biomedical 952-368-6244 ryan.lake@lifecore.com
FAQ
When will Lifecore Biomedical (LFCR) release Q3 2025 earnings?
What time is Lifecore Biomedical's (LFCR) Q3 2025 earnings call?
How long will LFCR's Q3 2025 earnings webcast recording be available?
Where can I access Lifecore Biomedical's (LFCR) Q3 2025 earnings webcast?
